Board certified in medical oncology, Suresh S. Ramalingam, MD, FACP, FASCO, is nationally recognized as an investigator and a physician in the area of small cell and non-small cell lung cancer.
Dr. Ramalingam serves as executive director of Winship Cancer Institute of Emory University and associate vice president for cancer of Woodruff Health Sciences Center. He is past-president of the Georgia Society of Oncology and a member of the board of Georgia CORE. He is a Fellow of the American Society of Clinical Oncology and a Georgia Cancer Coalition Distinguished Cancer Scholar.
Dr. Ramalingam holds professional memberships with American Society of Clinical Oncology, American Association for Cancer Research and International Association of Lung Cancer Study. He plays an active role in the ECOG-ACRIN Cancer Research Group as the Chair of the Thoracic Malignancies Committee and as the Deputy Chair of Therapeutics Programs. He serves on several international, national and institutional committees. He is a member of the Medical Oncology Board Exam Committee for American Board of Internal Medicine.
Dr. Ramalingam's present research involves developing immune checkpoint inhibitors and improving outcomes for patients with EGFR mutation.
Dr. Ramalingam has conducted several phase 1, 2 and 3 clinical trials with molecularly targeted agents in the treatment of small cell and non-small cell lung cancer.
|
|
|
| Grant Number | Title |
|---|---|
Dr. Ramalingam has authored over 300 scientific publications. He serves as editor-in-chief of CANCER, a peer-reviewed journal of the American Cancer Society.
As a physician scientist, Dr. Ramalingam has received numerous peer-reviewed grants from the National Cancer Institute. He is also the recipient of several awards including the James Eckman Award for Excellence in Teaching at Emory, ECOG-ACRIN Young Investigator Award and NCI Cancer Clinical Investigator Team Leadership Award. He has been consistently listed in Atlanta Magazine's annual "Top Doctors" issue since 2018.
Dr. Ramalingam has been named to the MilliPub Club, which recognizes current Emory University School of Medicine faculty who have published one or more individual papers throughout their careers that have garnered more than 1,000 citations.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
| 4.9 | Provider showed concern | |
| 4.9 | Provider explained things clearly | |
| 4.9 | Provider discussed treatment options | |
| 4.9 | Provider included you in decisions | |
| 4.9 | Likelihood of recommending this provider |
